Cargando…

A Randomized Clinical Trial to Evaluate the Effects of Safinamide on Apathetic Non-demented Patients With Parkinson's Disease

BACKGROUND: Apathy is highly prevalent and disabling in Parkinson's disease (PD). Pharmacological options for its management lack sufficient evidence. OBJECTIVE: We studied the effects of safinamide on apathy in PD. METHODS: Prospective, 24-week, two-site, randomized, double-blind, placebo-cont...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kulisevsky, Jaime, Martínez-Horta, Saul, Campolongo, Antonia, Pascual-Sedano, Berta, Marín-Lahoz, Juan, Bejr-kasem, Helena, Aracil-Bolaños, Ignacio, Horta-Barba, Andrea, Puig-Davi, Arnau, Pagonabarraga, Javier
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Neurology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9201638/ https://www.ncbi.nlm.nih.gov/pubmed/35720066 http://dx.doi.org/10.3389/fneur.2022.866502

Ejemplares similares

The Free and Cued Selective Reminding Test in Parkinson's Disease Mild Cognitive Impairment: Discriminative Accuracy and Neural Correlates
por: Horta-Barba, Andrea, et al.
Publicado: (2020)

Measuring the functional impact of cognitive impairment in Huntington’s disease
por: Horta-Barba, Andrea, et al.
Publicado: (2022)

Tremor Types in Parkinson Disease: A Descriptive Study Using a New Classification
por: Gironell, Alexandre, et al.
Publicado: (2018)

Parkinson's Disease: Impulsivity Does Not Cause Impulse Control Disorders but Boosts Their Severity
por: Marín-Lahoz, Juan, et al.
Publicado: (2018)

Interaction between sex and neurofilament light chain on brain structure and clinical severity in Huntington’s disease
por: Sampedro, Frederic, et al.
Publicado: (2021)

Early Gray Matter Volume Loss in MAPT H1H1 de Novo PD Patients: A Possible Association With Cognitive Decline
por: Sampedro, Frederic, et al.
Publicado: (2018)

Structural brain correlates of dementia in Huntington’s disease
por: Martinez-Horta, Saul, et al.
Publicado: (2020)

A Spanish Consensus on the Use of Safinamide for Parkinson’s Disease in Clinical Practice
por: Pagonabarraga, Javier, et al.
Publicado: (2020)

Genotype–Phenotype Correlation in Progressive Supranuclear Palsy Syndromes: Clinical and Radiological Similarities and Specificities
por: Ruiz-Barrio, Iñigo, et al.
Publicado: (2022)

Detection of genomic rearrangements from targeted resequencing data in Parkinson's disease patients
por: Spataro, Nino, et al.
Publicado: (2016)

Safinamide in Clinical Practice: A Spanish Multicenter Cohort Study
por: Martí-Andrés, Gloria, et al.
Publicado: (2019)

Long-term Efficacy of Safinamide on Parkinson’s Disease Chronic Pain
por: Cattaneo, Carlo, et al.
Publicado: (2018)

Facial Emotion Recognition Impairment in Patients with Parkinson's Disease and Isolated Apathy
por: Martínez-Corral, Mercè, et al.
Publicado: (2010)

ODP655 Apathetic Hyperthyroidism
por: Seetharaman, Kavita
Publicado: (2022)

Erratum: Pagonabarraga, J.; et al. A Spanish Consensus on the Use of Safinamide for Parkinson’s Disease in Clinical Practice. Brain Sci. 2020, 10, 176
por: Pagonabarraga, Javier, et al.
Publicado: (2020)

Apathetic thyrotoxicosis presenting with diabetes mellitus
por: Poudel, Resham R., et al.
Publicado: (2014)

Safinamide in the treatment pathway of Parkinson’s Disease: a European Delphi Consensus
por: Stocchi, Fabrizio, et al.
Publicado: (2022)

Gray Matter Volume Changes in the Apathetic Elderly
por: Yan, Hongjie, et al.
Publicado: (2015)

Types of apathetic depressions formed in endogenous diseases.
por: Barkhatova, A., et al.
Publicado: (2023)

The impact of dopaminergic treatment over cognitive networks in Parkinson's disease: Stemming the tide?
por: Aracil‐Bolaños, Ignacio, et al.
Publicado: (2021)

Pattern of Regional Cortical Thinning Associated with Cognitive Deterioration in Parkinson’s Disease
por: Pagonabarraga, Javier, et al.
Publicado: (2013)

Atrial Fibrillation as an Initial Presentation of Apathetic Thyroid Storm
por: Ali, Hassam, et al.
Publicado: (2021)

Severity Stages in Essential Tremor: A Long-Term Retrospective Study Using the Glass Scale
por: Gironell, Alexandre, et al.
Publicado: (2015)

The effects of safinamide on dysphagia in Parkinson’s disease
por: Hirano, Makito, et al.
Publicado: (2023)

A European Observational Study to Evaluate the Safety and the Effectiveness of Safinamide in Routine Clinical Practice: The SYNAPSES Trial(1)
por: Abbruzzese, Giovanni, et al.
Publicado: (2021)

Measuring cognitive impairment and monitoring cognitive decline in Huntington’s disease: a comparison of assessment instruments
por: Horta-Barba, Andrea, et al.
Publicado: (2023)

Effects of a Green Oat Herb Extract on Cognitive Performance and Neurophysiological Activity: A Randomized Double-Blind Placebo-Controlled Study
por: Martinez-Horta, Saul, et al.
Publicado: (2021)

Safinamide: an add-on treatment for managing Parkinson’s disease
por: Müller, Thomas
Publicado: (2018)

SURINPARK: Safinamide for Urinary Symptoms in Parkinson’s Disease
por: Gómez-López, Ana, et al.
Publicado: (2021)

Patterns of endogenous steroids in apathetic refugee children are compatible with long-term stress
por: Söndergaard, Hans Peter, et al.
Publicado: (2012)

Neuroimaging Analysis of the Dopamine Basis for Apathetic Behaviors in an MPTP-Lesioned Primate Model
por: Tian, LinLin, et al.
Publicado: (2015)

PM301. Neuroanatomical pathways associated with post-stroke affective and apathetic depression
por: Yamashita, Hidehisa, et al.
Publicado: (2016)

Apathetic encephalopathy in thyreotoxicosis: an unsual cause of Wernicke Encephalopathy and osmotic demyelinating syndrome
por: Mutti, Carlotta, et al.
Publicado: (2021)

Matemática demente /
por: Carroll, Lewis, 1832-1898
Publicado: (1983)

Matemática demente /
por: Carroll, Lewis, 1832-1898
Publicado: (1975)

The Dement in the Community
por: Addis, R. S.
Publicado: (1960)

Dementing Prions
por: Mahler, Robert
Publicado: (1996)

Investigational agents in the treatment of Parkinson’s disease: focus on safinamide
por: Malek, Naveed M, et al.
Publicado: (2012)

Adjuvant therapies for Parkinson’s disease: critical evaluation of safinamide
por: Stocchi, Fabrizio, et al.
Publicado: (2016)

Emerging approaches in Parkinson’s disease – adjunctive role of safinamide
por: Müller, Thomas
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_uu25gnb31ihjrtmetkvt2unosd